Short Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Declines By 86.7%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) saw a large drop in short interest in the month of February. As of February 28th, there was short interest totalling 9,700 shares, a drop of 86.7% from the February 13th total of 73,200 shares. Based on an average daily volume of 132,300 shares, the days-to-cover ratio is currently 0.1 days.

Tevogen Bio Trading Down 6.0 %

NASDAQ TVGNW traded down $0.00 during trading on Wednesday, reaching $0.06. 53,632 shares of the company’s stock traded hands, compared to its average volume of 159,705. The company’s 50 day simple moving average is $0.07 and its two-hundred day simple moving average is $0.05. Tevogen Bio has a 12-month low of $0.01 and a 12-month high of $0.15.

About Tevogen Bio

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.